We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Confounders Regarding the Association of Insulin Resistance and Alzheimer Disease—Reply

Auriel A. Willette, PhD1; Barbara B. Bendlin, PhD2
[+] Author Affiliations
1Iowa State University, Ames
2University of Wisconsin–Madison
JAMA Neurol. 2016;73(2):240-241. doi:10.1001/jamaneurol.2015.3986.
Text Size: A A A
Published online


In Reply Muratli et al propose several important ideas that warrant consideration. Similar to the International Expert Committee,1 they point out that the hemoglobin A1c percentage is a more reliable index of hyperglycemia than fasting glucose. We agree this is an important consideration and our more recent studies now routinely collect hemoglobin A1c. Collecting fasting glucose at multiple points is also a fair consideration. However, regardless of how type 2 diabetes mellitus is diagnosed, we point out that covarying type 2 diabetes mellitus status or hyperglycemia (blood glucose level ≥100 mg/dL; to convert to millimoles per liter, multiply by 0.0555) yields nearly identical results in several studies, such as in our study,2 which used the homeostatic model assessment of insulin resistance. It is likely the case in this study and other reports that the degree of hyperinsulinemia, rather than hyperglycemia, is driving associations with brain outcomes.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





February 1, 2016
Sevilay Muratli, MD; Ozlem Soyluk, MD; Fatih Tufan, MD
1Department of Internal Medicine, Division of Geriatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
2Department of Gerontology, Faculty of Medical Sciences, Istanbul University, Istanbul, Turkey
JAMA Neurol. 2016;73(2):239-240. doi:10.1001/jamaneurol.2015.3983.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...